A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-based Treatment Combinations or MK-5684 Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC).
Principal Investigator: Heikki Junkkari
Trial site: HUS Comprehensive Cancer Center
Please refer to the ClinicalTrials register for study information
